1,904 results on '"Kida, Hiroshi"'
Search Results
2. Gas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary disease
3. Epidemiology of bronchiectasis at a single center in Japan: a retrospective cohort study
4. The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycobacterial pulmonary disease
5. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine
6. Exercise intolerance and oxygen dynamics in nontuberculous mycobacteria with bronchiectasis
7. Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaques
8. The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir
9. The elucidation of plasma lipidome profiles during severe influenza in a mouse model
10. A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19
11. Virulence of Mycobacterium intracellulare clinical strains in a mouse model of lung infection – role of neutrophilic inflammation in disease severity
12. Invariant natural killer T cells and iron metabolism orchestrate skin development and homeostasis
13. Refractory phenotype of Aspergillus-sensitized asthma with bronchiectasis and allergic bronchopulmonary aspergillosis
14. Chronic Pulmonary Disease Caused by Tsukamurella toyonakaense
15. Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19
16. Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients
17. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
18. CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
19. Specific targeting of lung ILC2s via NRP1 in pulmonary fibrosis
20. Impact of bronchial wall thickness on airflow obstruction in bronchiectasis
21. Hemagglutinin and neuraminidase of an H7N7 non-pathogenic avian influenza virus coevolved during the acquisition of intranasal pathogenicity in chickens
22. Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire
23. Serum GPL core antibody levels are associated with disease activity and treatment outcomes in Mycobacterium avium complex lung disease following first line antibiotic treatment
24. In vitro anti-inflammatory and anti-lipid accumulation properties of taxifolin-rich extract from the Japanese larch, Larix kaempferi
25. Spatiotemporal and risk analysis of H5 highly pathogenic avian influenza in Vietnam, 2014–2017
26. A cloned classical swine fever virus derived from the vaccine strain GPE− causes cytopathic effect in CPK-NS cells via type-I interferon-dependent necroptosis
27. Intracranial Gene Delivery Mediated by Albumin-Based Nanobubbles and Low-Frequency Ultrasound
28. Epidemiology of Non-Cystic Fibrosis Bronchiectasis at a Single Centre in Japan: A Retrospective Cohort Study
29. Recent Trends in Application of Encapsulated Ultrafine Bubbles in Medicine
30. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
31. Critical role of oxidized LDL receptor-1 in intravascular thrombosis in a severe influenza mouse model
32. Pulmonary eosinophilia may indicate onset stage of allergic bronchopulmonary aspergillosis
33. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis
34. Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models
35. Defining the kinetic effects of infection with influenza virus A/PR8/34 (H1N1) on sphingosine-1-phosphate signaling in mice by targeted LC/MS
36. Genetic and antigenic characterization of H5 and H7 avian influenza viruses isolated from migratory waterfowl in Mongolia from 2017 to 2019
37. Revealing the diversity of neutrophil functions and subsets
38. Cell cytotoxity and anti-glycation activity of taxifolin-rich extract from Japanese larch, Larix kaempferi
39. Evaluation of a rapid isothermal nucleic acid amplification kit, Alere™ i Influenza A&B, for the detection of avian influenza viruses
40. 2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses
41. Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report
42. A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease
43. Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report
44. Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis
45. Mouse model of Epstein–Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease
46. Avian Influenza in Japan: Antigenic and Genetic Analyses of the Hemagglutinin of H3 Influenza Viruses of Duck Origin
47. Avian Influenza Virus as the Origin of Human Pandemic Strains
48. Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice
49. Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus
50. Cell-penetrating peptide-mediated cell entry of H5N1 highly pathogenic avian influenza virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.